Clinical Research Directory
Browse clinical research sites, groups, and studies.
Hellenic Evaluation of the Long-Term Safety and Efficacy of NalIriFOx as a 1st-line Therapy in Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC)
Sponsor: Hellenic Cooperative Oncology Group
Summary
This is multicenter, prospective, open label, non-interventional study that will collect real-world data (RWD) on the clinical efficacy and safety of NalIriFOx as a first-line therapy in metastatic pancreatic ductal adenocarcinoma (mPDAC).
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
70
Start Date
2026-03-30
Completion Date
2029-03-30
Last Updated
2026-07-24
Healthy Volunteers
No
Locations (9)
Attikon University General Hospital
Athens, Greece
General Oncology Hospital Agioi Anargyroi
Athens, Greece
HYGEIA Hospital
Athens, Greece
HYGEIA Hospital
Athens, Greece
2nd Oncology Department, Metropolitan Hospital
Athens, Greece
Ippokratio
Athens, Greece
Larissa University General Hospital
Larissa, Greece
General Hospital Agios Andreas
Pátrai, Greece
Thessaloniki General Hospital "George Papanikolaou"
Thessaloniki, Greece